These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 15711261

  • 21. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
    Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA.
    J Clin Oncol; 2007 Jul 20; 25(21):3076-81. PubMed ID: 17634486
    [Abstract] [Full Text] [Related]

  • 22. Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less.
    Ito K, Yamamoto T, Ohi M, Takechi H, Kurokawa K, Suzuki K, Yamanaka H.
    Prostate; 2003 Sep 15; 57(1):8-13. PubMed ID: 12886518
    [Abstract] [Full Text] [Related]

  • 23. Digital rectal examination is barrier to population-based prostate cancer screening.
    Nagler HM, Gerber EW, Homel P, Wagner JR, Norton J, Lebovitch S, Phillips JL.
    Urology; 2005 Jun 15; 65(6):1137-40. PubMed ID: 15922431
    [Abstract] [Full Text] [Related]

  • 24. Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable.
    Hugosson J, Aus G, Lilja H, Lodding P, Pihl CG, Pileblad E.
    J Urol; 2003 May 15; 169(5):1720-3. PubMed ID: 12686817
    [Abstract] [Full Text] [Related]

  • 25. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
    Srinualnad S, Charoenkraikamol C, Toraksa S, Uiprasertkul M, Amornvesukit T, Taweemonkongsap T, Udompunturak S, Nualyong C, Tantiwong A.
    J Med Assoc Thai; 2006 Jan 15; 89(1):37-42. PubMed ID: 16583579
    [Abstract] [Full Text] [Related]

  • 26. Characteristics of prostate cancer detected by digital rectal examination only.
    Okotie OT, Roehl KA, Han M, Loeb S, Gashti SN, Catalona WJ.
    Urology; 2007 Dec 15; 70(6):1117-20. PubMed ID: 18158030
    [Abstract] [Full Text] [Related]

  • 27. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
    Price MM, Hamilton RJ, Robertson CN, Butts MC, Freedland SJ.
    Urology; 2008 May 15; 71(5):787-91. PubMed ID: 18267334
    [Abstract] [Full Text] [Related]

  • 28. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings.
    Luciani LG, De Giorgi G, Valotto C, Zanin M, Bierti S, Zattoni F.
    Urology; 2006 Mar 15; 67(3):555-8. PubMed ID: 16527579
    [Abstract] [Full Text] [Related]

  • 29. Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.
    Chun FK, Perrotte P, Briganti A, Benayoun S, Lebeau T, Ramirez A, Lewinshtein DJ, Valiquette L, Guay JP, Karakiewicz PI.
    BJU Int; 2006 Jul 15; 98(1):50-3. PubMed ID: 16831142
    [Abstract] [Full Text] [Related]

  • 30. Detection rate of prostate cancer according to prostate-specific antigen and digital rectal examination in Korean men: a nationwide multicenter study.
    Seo HK, Chung MK, Ryu SB, Lee KH, Korean Urological Oncologic Society Prostate Cancer Study Group.
    Urology; 2007 Dec 15; 70(6):1109-12. PubMed ID: 18158028
    [Abstract] [Full Text] [Related]

  • 31. [Screening for early detection of prostate cancer (first experience in Israel)].
    Neheman A, Shotland Y, Metz Y, Stein A.
    Harefuah; 2001 Jan 15; 140(1):4-10, 88, 87. PubMed ID: 11242898
    [Abstract] [Full Text] [Related]

  • 32. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I, Weiss NS, Lin DW, Stanford JL.
    Cancer Causes Control; 2007 Nov 15; 18(9):931-7. PubMed ID: 17641982
    [Abstract] [Full Text] [Related]

  • 33. Screening for prostate cancer at low PSA range: the impact of digital rectal examination on tumor incidence and tumor characteristics.
    Gosselaar C, Roobol MJ, Roemeling S, van der Kwast TH, Schröder FH.
    Prostate; 2007 Feb 01; 67(2):154-61. PubMed ID: 17044079
    [Abstract] [Full Text] [Related]

  • 34. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ, Sun L, Kane CJ, Presti JC, Terris MK, Amling CL, Moul JW, Aronson WJ.
    BJU Int; 2008 Sep 01; 102(8):969-74. PubMed ID: 18691175
    [Abstract] [Full Text] [Related]

  • 35. Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer.
    Schröder FH, Roobol MJ.
    Curr Opin Urol; 2009 May 01; 19(3):227-31. PubMed ID: 19357513
    [Abstract] [Full Text] [Related]

  • 36. Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial.
    Määttänen L, Hakama M, Tammela TL, Ruutu M, Ala-Opas M, Juusela H, Martikainen P, Stenman UH, Auvinen A.
    Br J Cancer; 2007 Jan 15; 96(1):56-60. PubMed ID: 17213825
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A comparison of first and repeat (four years later) prostate cancer screening in a randomized cohort of a symptomatic men aged 55-75 years using a biopsy indication of 3.0 ng/ml (results of ERSPC, Rotterdam).
    Roobol MJ, Schröder FH, Kranse R, ERSPC, Rotterdam.
    Prostate; 2006 May 01; 66(6):604-12. PubMed ID: 16388508
    [Abstract] [Full Text] [Related]

  • 39. Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer: European randomized study of screening for prostate cancer, Rotterdam.
    Beemsterboer PM, de Koning HJ, Kranse R, Trienekens PH, van der Maas PJ, Schröder FH.
    J Urol; 2000 Oct 01; 164(4):1216-20. PubMed ID: 10992369
    [Abstract] [Full Text] [Related]

  • 40. Community-based prostate cancer screening in Japan: predicting factors for positive repeat biopsy.
    Okada K, Okihara K, Kitamura K, Mikami K, Ukimura O, Kawauchi A, Kamoi K, Nakao M, Miki T.
    Int J Urol; 2010 Jun 01; 17(6):541-7. PubMed ID: 20438595
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.